    <SEC-DOCUMENT>0000950170-25-060099-index.html : 20250429
    <SEC-HEADER>0000950170-25-060099.hdr.sgml : 20250429
    <ACCEPTANCE-DATETIME>20250429160613
    ACCESSION NUMBER:		0000950170-25-060099
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20241231
    FILED AS OF DATE:		20250429
    DATE AS OF CHANGE:		20250429
    EFFECTIVENESS DATE:		20250429

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			ARS Pharmaceuticals, Inc.
    		CENTRAL INDEX KEY:			0001671858
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				811489190
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-39756
    		FILM NUMBER:		25887180

    	BUSINESS ADDRESS:
    		STREET 1:		11682 EL CAMINO REAL, SUITE 120
    		CITY:			SAN DIEGO
    		STATE:			CA
    		ZIP:			92130
    		BUSINESS PHONE:		858-771-9307

    	MAIL ADDRESS:
    		STREET 1:		11682 EL CAMINO REAL, SUITE 120
    		CITY:			SAN DIEGO
    		STATE:			CA
    		ZIP:			92130

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Silverback Therapeutics, Inc.
    		DATE OF NAME CHANGE:	20160412
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>ars_for_proxy_april_2025.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: ars_for_proxy_april_2025.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>